Answers are grounded in this paper and cite their sources.
Great interest in macrophage heterogeneity in the genesis and progression of atherosclerosis has led to the search for consistent markers of specific subsets in both animal models and humans. A better understanding of the overlap and competition between CSF regulation of macrophage phenotypes is therefore warranted, to allow their characterization in plaques. Subsequent targeted genetic and pharmacological intervention will facilitate the generation of therapeutic approaches to halt the progression and rupture of advanced atherosclerotic plaques.
No takes yet. Share an insight, caveat, or question.
Gregoli et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: